← Leaderboards
Joel S. Bader
Curagen Corporation
$9,157,907
Attributed
$13,173,515
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$13,173,515 · 12
By mechanism
U01$4,805,544 · 1
U54$4,720,188 · 5
R01$3,074,987 · 1
R41$282,548 · 2
R43$150,686 · 1
P30$122,562 · 1
Top collaborators
- Andrew Josef Ewald5 shared
- Petros C Karakousis4 shared
- Martin G Reese1 shared
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsComplexInsightGene ExpressionBaseComputational TechniqueGenesIn VivoKnock-OutSamplingMolecular ModelingDesignGrowthMolecularAreaTechnologyGenomeGenomicsGeneticMemberSuccessHuman DiseaseBiologicalInnovation
Grant awards (19)
Bioinformatics/Modeling/Biostatistics Core$122,562
P30 · FY2022 · AI · contact PI
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases$982,500
U01 · FY2021 · CA · contact PI
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases$982,500
U01 · FY2020 · CA · contact PI
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases$950,528
U01 · FY2019 · CA · contact PI
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases$974,850
U01 · FY2018 · CA · contact PI
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases$915,166
U01 · FY2017 · CA · contact PI
Networks, Pathways and Dynamics of Lysine Modification$3,444,217
U54 · FY2013 · GM · contact PI
A Multidisciplinary Approach to Understanding TB Latency and Reactivation$716,068
R01 · FY2013 · HL
A Multidisciplinary Approach to Understanding TB Latency and Reactivation$769,928
R01 · FY2012 · HL
A Multidisciplinary Approach to Understanding TB Latency and Reactivation$788,317
R01 · FY2011 · HL
A Multidisciplinary Approach to Understanding TB Latency and Reactivation$800,674
R01 · FY2010 · HL
Genetic Hotspots for Disease Risk$150,686
R43 · FY2010 · HG
CORE 3: INFRASTRUCTURE$349,064
U54 · FY2008 · RR · contact PI
CORE 3: INFRASTRUCTURE$327,388
U54 · FY2007 · RR · contact PI
Structural, Functional & Evolutionary Genomics Gordon Conference$17,000
R13 · FY2007 · HG · contact PI
CORE 3: INFRASTRUCTURE$310,401
U54 · FY2006 · RR · contact PI
Comparative systematic genetics for cardiovascular disease gene identification$182,732
R41 · FY2006 · HL · contact PI
CORE 3: INFRASTRUCTURE$289,118
U54 · FY2005 · RR
Mapping disease-specific human protein networks$99,816
R41 · FY2005 · GM